Patient Experiences With Integrated Pain Care: A Qualitative Evaluation of One VAs Biopsychosocial Approach to Chronic Pain Treatment and Opioid Safety. by Purcell, Natalie et al.
UCSF
UC San Francisco Previously Published Works
Title
Patient Experiences With Integrated Pain Care: A Qualitative Evaluation of One VAs 
Biopsychosocial Approach to Chronic Pain Treatment and Opioid Safety.
Permalink
https://escholarship.org/uc/item/1ww4g3pm
Authors
Purcell, Natalie
Zamora, Kara
Gibson, Carolyn
et al.
Publication Date
2019
DOI
10.1177/2164956119838845
 
Peer reviewed
eScholarship.org Powered by the California Digital Library
University of California
Integrative Medicine for Chronic Pain Management - Original Article
Patient Experiences With Integrated Pain
Care: A Qualitative Evaluation of One VA’s
Biopsychosocial Approach to Chronic
Pain Treatment and Opioid Safety
Natalie Purcell, PhD, MPA1,2 , Kara Zamora, MA1,2,
Carolyn Gibson, PhD1,2, Jennifer Tighe, MSPH1,
Jamie Chang, PhD1,3, Joseph Grasso, PhD1, and
Karen H Seal, MD, MPH1,2
Abstract
Background: Mounting concern about the risks and limited effectiveness of opioid therapy for chronic pain has spurred the
implementation of novel integrated biopsychosocial pain care models in health-care systems like the Department of Veterans
Affairs (VA). However, little is known about patient experiences with these new care models.
Objective: We conducted a qualitative study to examine patient experiences with a pain care model currently being
disseminated at the VA: interdisciplinary, integrated pain teams (IPTs) embedded in primary care.
Method: We interviewed 41 veterans who received care from VA’s first IPT to learn how working with the team impacted
their pain care and quality of life. We asked about their overall experience with IPT, what worked and did not work for them,
and what changes they would recommend to improve IPT care.
Results: The interviews revealed a wide spectrum of patient experiences and varying perspectives on the extent to which
the new model improved their pain and quality of life. Thematic analysis shed light on factors impacting patients’ experiences,
including pretreatment goals and expectations as well as attitudes toward opioids and nonpharmacological treatments.
Conclusion:We discuss the implications of our findings for national efforts to implement biopsychosocial pain care, and we
offer recommendations to promote patient-centered implementation.
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Introduction
In the United States, reliance on opioids for chronic pain
care has contributed to an overdose epidemic that claims
thousands of lives annually.1–3 Opioid-related deaths
have increased by 200% since 2000,4 prompting the dec-
laration of a national public health emergency in 2017.5
Beyond overdose risk, long-term prescription opioid use
has concerning side effects that can decrease quality of
life and daily functioning.6 Today, there is significant
evidence of harm, but little evidence supporting the
effectiveness of opioid therapy for long-term chronic
pain treatment.7–11
Patients are often dissatisfied with conventional pain
care and its reliance on opioids. Many report that,
despite treatment, chronic pain continues to affect their
health, relationships, happiness, and quality of life.12–14
Patients often describe frustrating relationships with the
providers treating their pain, citing power struggles,
and conflicts surrounding treatment decisions.15–20
Communication about opioids can be particularly
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tense, and patients often report feeling like providers are
not listening to them or view them as addicts rather than
human beings in pain.
Today, most chronic pain care is delivered in primary
care settings, prompting recent efforts to introduce new
pain care models into primary care.21–25 A growing body
of evidence now documents the safety and efficacy of
multiple integrative and nonpharmacological modalities
in improving pain symptoms, quality of life, and function-
ing.26 These modalities include psychological and behav-
ioral therapies, exercise and movement therapies, and
manual therapies, ideally delivered in combination with
one another and alongside pharmacological treatments.
Studies suggest that integrated pain care models can
effectively reduce patient reliance on opioids,24 improve
pain-related functioning,24 and improve primary care
providers’ experience.25 Indeed, emerging best practices
and clinical guidelines increasingly recommend multi-
modal, biopsychosocial care as the gold standard for
chronic pain treatment.26–31 However, it is not yet
clear whether integrated care models also improve
patients’ care experience.
In the current study, we examined patients’ experien-
ces with an integrated pain care model embedded in
Department of Veterans Affairs (VA) primary care and
currently being implemented across multiple sites in the
national VA health-care system. We conducted semi-
structured qualitative interviews to explore patients’
overall experiences and satisfaction and to identify fac-
tors affecting their perspectives on integrated, multimod-
al pain care.
Methods
Setting
The present study (approved by the University of
California, San Francisco Institutional Review Board)
is part of a larger quality improvement research initiative
evaluating implementation of an integrated pain team
(IPT) care model throughout the San Francisco VA
Health Care System—a public health-care system serv-
ing over 40,000 U.S. military veterans. Participating
campuses included an urban VA medical center; 2
small, urban outpatient campuses and 3 small, rural out-
patient campuses.
Intervention
The IPT care model24,25 provides integrated, interdisci-
plinary chronic pain care within VA primary care set-
tings. Primary care providers refer patients with complex
chronic pain to IPT, often due to concerns about opioid
safety, opioid misuse, and/or co-occurring mental health
diagnoses. Referred patients see IPT’s medical provider,
psychologist, and pharmacist as a unified interdisciplin-
ary team. All providers are present for the initial visit
and, as appropriate, follow-up visits. During these visits,
the team educates patients about chronic pain, medica-
tion safety, and a biopsychosocial approach to pain
management. The team works with each patient to opti-
mize a personalized pain care plan that addresses pain
symptoms, improves quality of life, and reduces opioid
risk. IPT takes over pain-medication prescribing and
often initiates and oversees opioid tapers for patients
in their care. IPT care plans typically include behavioral
interventions and psychotherapy and emphasize self-
management strategies. Additionally, the team provides
information about and coordinates referrals to ancillary
and complementary health services, including physical
therapy and acupuncture.
At San Francisco VA, patients average 3 to 4 visits
with IPT over 2 to 3 months before returning to primary
care for pain management. However, the number and
frequency of visits vary significantly based on patient
needs and preferences.25 Veterans served by the urban
medical center and its nearby campuses see IPT primarily
through in-person visits with some telephone follow-up.
Veterans served by rural VA clinics see IPT primarily
through video-teleconferencing with telephone follow-up.
Design
We used a qualitative study design to evaluate patients’
experiences with IPT, inviting those who received IPT
care to participate in a telephone interview after com-
pleting at least 3 IPT visits.
Measures
We developed a semistructured interview instrument
comprised of questions about: (1) veterans’ overall expe-
rience working with IPT, (2) IPT’s impact on their pain
care and quality of life, and (3) what did and did not
work well in the IPT care model. Across all areas, we
solicited patient concerns and recommendations to
inform future iterations of the model.
Participants
Eligible participants included veterans with chronic pain
diagnoses who enrolled in IPT care at San Francisco VA
and completed at least 3 IPT visits. Patients were exclud-
ed if they had untreated serious mental illness or were
actively suicidal or homicidal. All eligible veterans
(n¼ 84) were invited to participate via a letter from the
study team and a follow-up telephone call to those who
did not return an “opt-out” postcard.
Interviews were completed for 41 veterans (response
rate¼ 49%, see Table 1). Participants were predomi-
nantly male (66%), white (66%), and middle-aged
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(mean age 58 years). Military service-related disabilities
were documented for 63% of participants.
Procedures
Study team members trained in qualitative assessment
conducted all interviews via telephone. Interview times
typically ranged between 30 and 60 min. All interviews
were audio-recorded for analysis.
Analytic Strategy
We used a qualitative analysis technique developed for
rapid health services research.32 Using our semistruc-
tured interview guide, we created an analytic matrix tem-
plate organized by topical area. Guided by the interview
audio-recordings, we populated a matrix for each inter-
view, summarizing interview content for all topical areas
and transcribing participant quotations illustrating each
summary. To ensure reliability, at least 2 analysts com-
pleted a matrix for each individual interview and com-
pared their findings for consistency. The team then used
these matrices to identify and organize recurring themes
and to prepare a description of each theme. To ensure
validity, authors NP, KZ, and CG each reviewed the
matrices and independently identified themes. We met
routinely during the analysis phase to reconcile the
results of our analyses, to confirm that all central
themes had been identified, and to ensure consensus
around the description of each theme.
Results
Patient interviews revealed a wide spectrum of experiences
with IPT care. To illustrate this range of experiences and
to identify the factors driving them, we present themes
across 3 domains: (1) Interdisciplinary Treatment
Model, (2) Treatment Planning and Communication,
and (3) Treatment Results and Impact.
Interdisciplinary Treatment Model
Patients referred to IPT enter a multimodal care-
planning process with an interdisciplinary team of pro-
viders who meet together with the patient at the same
time. Many patients described this interdisciplinary care
model as both efficient and beneficial. They liked seeing
multiple clinicians with pain expertise in a single
appointment primarily because the team could address
various clinical needs and questions at once and follow a
cohesive treatment plan. One patient observed:
That’s never been something that I’ve ever had in a med-
ical facility—trying to facilitate a solution for me where
more than one person came into a room with their dif-
ferent expertise and collaboratively worked together to
promote higher understanding, and I think that’s what’s
really benefitted me.
Several veterans noted that receiving care from an inter-
disciplinary team meant they did not need to waste time
requesting referrals or making appointments to see dif-
ferent specialists. As one patient said, “Having them all
together let us all get it taken care of at one time.”
However, not all patients favored the interdisciplinary
model. Even after working with the team for months,
many could not differentiate the IPT providers or
recall their individual roles. Some felt that IPT’s inter-
disciplinary model added unnecessary complexity: “It’s
just taken the same thing and made it more confusing for
me,” observed one veteran. Dealing with “one provider
is better than five,” commented another.
Other patients noted that having multiple clinicians in
the room could feel awkward. The team-based visit
structure could leave them feeling outnumbered, intimi-
dated, and less inclined to engage. “You can feel a little
ganged up on,” noted one veteran. A few patients shared
mixed feelings about the presence of a mental health
provider. Some preferred to keep that aspect of their
care private or felt that mental health care was not help-
ful for their pain. “To me, talking about it doesn’t help,”
shared one veteran, “Obviously, my pain depresses me.”
Treatment Planning and Communication
A primary goal of IPT is to actively engage patients in
personalized care planning. However, patients provided
varied and, at times, conflicting perspectives about their
communication with IPT and their involvement in the
care-planning process.
On one end of the spectrum, many patients felt that
their personal goals were truly reflected in their care
planning. “They found out what my life is about and
what is important to me,” explained one veteran,
“I got to decide what I really wanted to work on, kind
Table 1. Characteristics of the Sample (n¼ 41).
Demographic Characteristics Participants, n (%)
Age, in years (mean) 58
Gender
Male 27 (65.85)
Female 14 (34.15)
Race
White 27 (65.85)
Black/African American 6 (14.63)
American Indian/Alaskan Native 1 (2.44)
Hispanic 1 (2.44)
Asian 1 (2.44)
Multiracial/Other 4 (9.76)
Military service-connected disability 26 (63.41)
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of what my goals were . . . It was tailored for me.”
Patients frequently noted that the team listened carefully
to them and addressed their questions and concerns,
often more so than in their usual health-care experiences.
“I felt like they heard me,” shared one veteran, “When
I told them ‘this is who I am, and this is what I do’ . . .
they weren’t trying to put a round peg in a square hole.”
Multiple patients valued the collaborative nature of the
care-planning process. “It’s a two-way conversation, not
a one way conversation, so it worked really well for me,”
shared one veteran.
Patients often spoke of how important it was to feel
that the team members cared about them as human
beings, investing time and attention to meet their needs:
They care, and that’s the biggest part . . . I think it’s
genuine . . .That gives a guy kind of a shot in the arm,
if you will. It gives me more incentive, because they
become part of my team and I don’t want to let
them down.
In some cases, having someone to talk to about their
pain met an otherwise unmet need for connection and
validation. “I think it’s honestly given me confidence on
managing my own pain and making decisions for
myself,” shared one veteran.
However, not all patient experiences were positive.
Some regarded the team with suspicion, worrying that,
if they answered questions about their pain and opioid
use honestly, they would be labeled an addict and have
their medications taken away. “You have to tell them
what they want to hear, or you’re in big trouble, trust
me,” affirmed one veteran, “I feel like I’m doing some-
thing illegal every time I take a pain pill . . . I’m scared to
death of what to say to them.”
Some patients felt that opioid dose reduction was
IPT’s singular “agenda” from the start. As one veteran
put it, “They just want to get the medications down, take
them away from me and that’s their goal.” To patients
who shared this view, IPT was not personalized pain
care but rather a mechanism to implement new VA pol-
icies around opioids. “I don’t feel that they necessarily
had my welfare as number one,” shared another veteran,
“I believe their main concern was just getting me off of
drugs.” The perceived discrepancy between what IPT
espoused (multimodal care options, patient-driven treat-
ment planning) and the care they felt they received
(focused on opioid dose reduction) left some patients
feeling misled and dissatisfied. These veterans described
the team’s claims about personalization and choice as a
“joke” or a “charade.” The most distressed and unhappy
patients said that IPT had treated them like “junkies” or
“drug addicts.”
Interviewed patients often referenced the national
opioid crisis, describing IPT as a part of VA’s effort to
rein in the use of opioids to prevent abuse and overdo-
ses. As one veteran put it, “Everybody is running so
scared behind Vicodin and whatever, that they’re more
concerned with that than trying to address someone’s
pain . . . it’s headline news.” When patients mentioned
the opioid crisis, some took pains to explicitly differen-
tiate themselves from its victims:
I saw on the news this morning . . . a million or whatever
people died in 2016 from opioid addiction or overdoses,
but that’s not me. I think each one of us should be taken
individually.
Patients’ perspectives on the national opioid crisis—and
their own relationship to it—thus shaped their impres-
sions of and feelings about IPT.
Treatment Results and Impact
IPT aims to improve pain, quality of life, and function-
ing with an explicitly multimodal approach, including a
range of nonpharmacological and behavioral strategies.
However, when we asked patients to reflect on how their
treatment plans changed during their time with IPT,
nearly all cited opioid reduction or elimination as the
most significant change.
Some felt that this change had a clear, positive
impact, resulting in greater energy, less grogginess, and
a renewed ability to engage in valued activities and rela-
tionships. Explained one veteran:
Since I don’t do as much morphine, I’ve started to get
myself back out and doing things I had stopped doing . . .
I [had] completely quit fishing and stuff and now I’ve got
it back to where I’ll go fishing once a week, and just
trying to be a little more of an active person.
Like him, many patients reported that IPT’s changes to
their medication regimen had a positive impact on their
pain and quality of life. For some, it was truly
life-changing:
It’s really definitely changed how I kind of carry myself,
I don’t feel like I’m a decrepit . . . aging, old woman, I feel
like, okay, I have a new lease on life.
However, other patients described worsening pain as
their opioid medications were reduced or changed, some-
times severely curtailing their functioning and quality of
life. “I’m spending half the time in the emergency room
curled up in the corner,” complained one veteran,
“The VA ruined my life.” Many of these patients said
that opioids had been the only effective means of treat-
ing their pain, and they felt that the negative impact of
opioid reduction was not offset by any alternative
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treatments or positive effects. Some expressed a sense of
desperation and resignation: “I just don’t know what
to do about the pain except live with it I guess . . . I’m
at a loss.”
Although most patients described adjustments to
their opioid regimen as the most significant change in
their treatment plan, several also described adding non-
pharmacological and integrative treatment modalities to
their care plan. The changes most often mentioned
were behavioral strategies including stress reduction,
mindfulness, activity pacing, and use of heat and ice.
Experiences with these modalities varied among inter-
viewees, but many found a few strategies they considered
helpful. The addition of acupuncture was frequently
described as a significant, if temporary, source of relief,
and some found acupuncture to be truly life-changing.
Others mentioned exercises and physical therapy as help-
ful additions to their care plan.
However, not all patients felt that behavioral strate-
gies and integrative modalities made an appreciable dif-
ference. Some doubted their effectiveness or found them
impractical. Several patients said that IPT offered them
nothing that they had not tried before:
They’ve suggested a thousand different things,
but . . . I’ve done so many different things. I’ve tried all
the things you can imagine, including acupuncture, acu-
pressure, physical therapy . . .There’s nothing that they
could suggest to me that I can think of that would be
different, or new.
It is notable that, although multimodal care-planning is
central to IPT’s mission, many interviewed patients were
not able to cite any nonpharmacological changes or
additions to their treatment plan.
Drivers of Patient Experience
The factor that most clearly shaped patients’ overall IPT
experience was whether they wanted to reduce their
opioid use. Patients who came to IPT with a goal to
reduce or stop opioids generally welcomed the team’s
support in this endeavor. These patients often spoke
warily of opioids, saying things like, “you don’t want
to get hooked on that stuff,” and using words like
“dope” and “chemicals” to describe the medications.
Other patients made no negative comments about
opioids but came to IPT with some interest in learning
about alternatives and safety considerations; they, too,
often reported positive IPT experiences. However, very
little satisfaction was reported among patients who
believed that opioids were the only effective treatment
for their pain—i.e., “there just isn’t any other medication
out there.”
Patients’ preexisting opinions about behavioral and
integrative treatment options also appeared to shape
their IPT experience. Those who noted that they were
already open to or excited about “holistic” or nonphar-
macological approaches to pain care tended to be the
most positive about IPT care. Others had little experi-
ence of these modalities but were interested and open to
them; among these patients, many were satisfied with
what IPT had to offer. By contrast, several dissatisfied
IPT patients expressed general skepticism about the
effectiveness of behavioral, integrative, and nonpharma-
cological approaches in addressing their pain, even dis-
missing them as “holistic this and that.”
Other veterans were open to developing multimodal
treatment plans but felt let down by the options available
to them. For example, women with childcare responsibil-
ities sometimes felt it was not realistic for them to partic-
ipate in groups or follow recommendations regarding rest
and pacing. As one veteran put it, “Some of their recom-
mendations would have been great for the general patient
population at the VA [older men], but they were just lousy
for someone who has to take care of young children.”
Similarly, patients in rural areas often felt like they did
not have access to the same community-based resources
as patients near urban campuses.
Patients’ experiences with IPT were also shaped by
how much control they felt they had in treatment plan-
ning. Patients who felt that their own treatment goals
were driving the process tended to have positive experi-
ences and reported more substantive and effective
changes to their treatment regimen. However, when
patients saw tapering opioids as IPT’s sole or primary
goal, they often felt less in control, less invested in
encounters with the team, and less satisfied with both
IPT’s process and outcomes. “The end game was already
defined,” explained one dissatisfied veteran, “A couple
times I said, ‘why are we having these meetings when
you already knew what you were gonna do before you
even met me?’”
The manner in which patients were referred to IPT
was also important. Patients who perceived IPT as an
additional choice available to them tended to be open to
working with the team and thankful for this option, even
if they were not always satisfied with the results. Patients
who were referred to IPT by their providers without a
discussion of their options tended to believe the referral
was a matter of policy rather than a choice and often had
more negative experiences.
Finally, the outlook that patients brought with them
appeared to shape to their overall experience in IPT.
A number of interviewed veterans spoke cynically
about the possibility of healing from pain, and those
patients were seldom happy with their IPT experience.
“I’ve tried everything else [and] it’s never worked,” said
one veteran, “and the medication only works so much,
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then after that I’m going to end up—I have to take more
medication.” In contrast, patients who felt hopeful
about the possibility of improvement tended to be
more positive in their descriptions of the IPT care pro-
cess and its outcomes. An extant sense of motivation and
engaged optimism tended to generate the most positive
IPT experiences. One veteran exemplified this attitude
when he said:
I think it’s up to each one of us to get in touch with our
own bodies, and figure out how to work around what we
have. And it’s just a matter of deciding, ‘do you want to
live, or are you gonna give up?’ And I’m a grandpa, and
I’ve got horses and I’ve got a pet dog, and I’ve got a
good life, and I’m not ready yet, so I’m gonna figure it
out. And these young people listen to me and they work
with me and I’m encouraged that I can do
this . . . I’m hopeful.
Discussion
There is mounting evidence that integrated, biopsycho-
social care models like IPT can reduce pain, improve
functioning, and reduce opioid-related risk.21–24
However, less is known about the impact of these care
models on patients’ experience. Our findings point
toward several ways that health-care institutions can
promote patient-centered care and improve patients’
experience when implementing integrated, biopsychoso-
cial pain care models.
First, our findings show the importance of transpar-
ency at the foundation of the pain care relationship.
The patients we interviewed were well aware of
the sociopolitical context undergirding VA’s shift
toward integrated and nonpharmacological pain care.
They knew that teams like IPT are, in part, a response
to the national opioid crisis. Many arrived with preexist-
ing impressions, including fears and concerns about their
medications being taken away. One approach that teams
like IPT might consider is to prioritize transparency
about this context from the start—not only referencing
the opioid crisis but also acknowledging that health-care
policies and practices contributed to, and helped create,
that crisis.33,34 Care teams can explicitly acknowledge
this and simultaneously convey awareness that each
patient is an individual with unique needs that are not
reducible to social trends or statistics. Doing so respects
patients’ knowledge about the broader context while cre-
ating space for them to voice their unique concerns and
needs. Such frank discussions might help lift the cloud of
suspicion and distrust that some patients felt in their
encounters with IPT.
Second, our findings suggest that engagement in any
pain care intervention should be an informed choice
among meaningful alternatives. We found that patients
who felt that they chose to work with IPT were often
able to build positive, collaborative relationships with
the team and felt like active, engaged drivers of their
own care. This was seldom the case for patients who
were referred without first having a discussion about
options with their primary care provider. To facilitate
informed choices about pain care, providers and patients
should have opportunities to learn about the structure,
aims, and potential benefits of available options, as well
as evidence of their impact. Teams like IPT might con-
sider offering recurring open informational sessions or
orientations for patients so they can better understand
the care model and ask questions before deciding
to engage.
Third, patients’ attitudes when they enter an interven-
tion like IPT may shape their receptivity to the model
and their satisfaction with treatment outcomes. Primary
care providers may wish to informally assess patients’
current attitudes toward opioids, nonpharmacological
pain treatment, and the care system as a whole before
making specific pain care referrals. Some patients may
benefit from additional education or coaching to
improve their readiness for specific pain care interven-
tions. Alternately, care models like IPT could be
modified to better facilitate the attitude shifts needed
for successful engagement. Possible changes that war-
rant further exploration include adding preliminary
motivational interviewing sessions and/or increasing
visit frequency and treatment duration.
Fourth, our findings show the importance of expand-
ing the menu of available integrative and nonpharmaco-
logical treatment options to meet the needs of a diverse
patient population. We learned that the options current-
ly available to IPT patients were not readily accessible to
all, and accessing them could pose particular challenges
for some patients, such as those with childcare respon-
sibilities and rural residents. The more treatment options
that teams like IPT can offer, the more likely they will be
to meet the needs of a diverse patient population.
Limitations
Our interviews were limited to IPT patients within one
VA health-care system, and our findings may not be
generalizable to nonveteran patients or to patients
receiving care at other VA facilities. Selection bias may
have affected our results as the perspectives of patients
who participated could differ in significant ways from
those who chose not to. The experiences of some patient
groups, such as young veterans of the wars in Iraq and
Afghanistan, were less well represented in our findings.
Also, our methodology may not have captured changes
in patient perspectives and experiences with continued
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IPT involvement beyond the 3-visit minimum required
for participation.
Despite these limitations, this study has many
strengths. For a qualitative interview-based study, our
sample was large (n¼ 41), and our response rate (nearly
50%) was robust. Our sample was reasonably diverse
with respect to race and gender and included patients
living throughout a large geographical area encompass-
ing urban, suburban, and rural locations.
Conclusion
As the VA and other health-care systems work to adopt
integrated, biopsychosocial approaches to pain care,
they can learn from the experiences of patients served
by IPT. Introducing biopsychosocial care options and
adopting integrated care models can facilitate an
improved patient experience but does not guarantee it.
Even good faith efforts to practice patient-centered care
may not feel patient-centered to everyone served, espe-
cially when tied to institutional imperatives like opioid
risk reduction. To build pain care models that leave
patients feeling respected and well cared for, care
teams must be attentive to the range of personal and
institutional factors that can shape patients’ experiences,
continually seeking ways to serve patients in their indi-
viduality and diversity.
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